Showing results (211-220 of 218) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCVAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.Ebiomedicine|July 12, 2020
Scleral HIF-1α is a prominent regulatory candidate for genetic and environmental interactions in human myopia pathogenesisFei Zhao, Dake Zhang, Qingyi Zhou, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2016
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Guowei Zhou, Craig A Coburn, et al.Journal of Medicinal Chemistry|February 18, 2014
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonistDuane DeMong, Xing Dai, Joyce Hwa, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.Pageof 22